Barclay Phillips

Director/Board Member at IMMUNIC, INC.

Net worth: - $ as of 31/05/2026

64 year

65 connections

Health Technology

Finance

Commercial Services

Profile

Mr. Barclay A. Phillips is a Chief Operating & Financial Officer at Ribometrix, Inc. and a Lead Independent Director at Immunic, Inc. He is on the Board of Directors at Immunic, Inc. and Immunic AG.
Mr. Phillips was previously employed as a CFO & Senior VP-Corporate Development by G1 Therapeutics, Inc., a Chief Financial Officer, Treasurer & Senior VP by Novavax, Inc., a Chief Financial Officer & Senior Vice President by Micromet, Inc. /MD/, a Managing Director by Vector Asset Management, Inc., a Managing Director by Vector Fund Management LP, a Director-Private Placements by INVESCO Funds Group, Inc., a General Partner by Apjohn Ventures LLC, a Director-Private Placements by INVESCO Institutional (N.A.), Inc., a Principal by PaineWebber, Inc., and a Principal by Shearson Lehman Hutton, Inc. He also served on the board at Acorda Therapeutics, Inc. and CancerVax Corp.
He received his undergraduate degree from the University of Colorado Boulder.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IMMUNIC, INC. -.--%	05/07/2026	0 ( -.--% )	- $	31/05/2026

Barclay Phillips active positions

Companies	Position	Start
IMMUNIC, INC.	Director/Board Member	19/11/2019
Immunic AG Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space	Director/Board Member	-
Ribometrix, Inc. Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease	Director of Finance/CFO	04/08/2020

All active positions of Barclay Phillips

Former positions of Barclay Phillips

Companies	Position	End
G1 THERAPEUTICS, INC.	Director of Finance/CFO	10/05/2019
NOVAVAX, INC.	Director of Finance/CFO	10/11/2017
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer	Director of Finance/CFO	29/07/2009
Vector Asset Management, Inc. Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years.	Chief Investment Officer	30/09/2008
Vector Fund Management LP Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL.	Corporate Officer/Principal	01/08/2008

See the detail of Barclay Phillips's experience

Training of Barclay Phillips

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barclay Phillips's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Novavax, Inc. Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines	Health Technology
Invesco Advisers, Inc. Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers provides a variety of services across a broad spectrum of investment strategies, sectors and asset classes. The firm utilizes several different methodologies, each predicated on a rigorous, bottom-up, value-oriented security selection process.	Finance
INVESCO Funds Group, Inc. INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO.	Finance
CancerVax Corp. CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer	Commercial Services
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies	Health Technology
Vector Fund Management LP Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL.	Finance
PaineWebber, Inc. PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services	Finance
Apjohn Ventures LLC Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures seeks investment opportunities in companies located in the United States, primarily in Michigan and the Midwest region. The firm focuses on life sciences such as pharmaceuticals, biotechnology, medical devices & diagnostics and healthcare services. It provides financing for early and later stage capital requirements with an investment size ranging from USD 0.5 to 2 million and also makes co-investments. It acts as a lead investor and it takes a seat on the board of directors.	Finance
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer	Health Technology
Shearson Lehman Hutton, Inc. Shearson Lehman Hutton, Inc. Investment Banks/BrokersFinance Provides investment banking services	Finance
Vector Asset Management, Inc. Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years.	Finance
G1 Therapeutics, Inc. G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment	Health Technology
University of Colorado Boulder University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Immunic AG Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space	Health Technology
Ribometrix, Inc. Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease	Health Technology
Immunic, Inc. Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases	Health Technology